Literature DB >> 16920493

Modulation of macrophage antimicrobial mechanisms by pathogenic mycobacteria.

Philipp Mueller1, Jean Pieters.   

Abstract

Tuberculosis remained a mysterious disease until Koch was able to demonstrate in the late 1800s that it was caused by a bacterium spread by aerosols, Mycobacterium tuberculosis. Today, tuberculosis still is a major health problem causing approximately 2 million deaths annually with about one third of the world's population being latently infected with M. tuberculosis. The secret of success for M. tuberculosis lies in its ability to persist inside host cells, the macrophages. Whereas macrophages are designed to destroy any incoming microbe, pathogenic mycobacteria have evolved strategies to survive within macrophages by preventing phagosome-lysosome fusion, thereby creating a niche that allows them to persist within an otherwise hostile environment. In this contribution, we discuss recent advances in our understanding of the interplay between the host and this pathogen that lead to survival of mycobacteria within macrophages.

Entities:  

Mesh:

Year:  2006        PMID: 16920493     DOI: 10.1016/j.imbio.2006.06.004

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  6 in total

Review 1.  Mycobacteria and innate cells: critical encounter for immunogenicity.

Authors:  Angelo Martino
Journal:  J Biosci       Date:  2008-03       Impact factor: 1.826

2.  Characterizing the Mycobacterium tuberculosis Rv2707 protein and determining its sequences which specifically bind to two human cell lines.

Authors:  Julie A Chapeton-Montes; David F Plaza; Hernando Curtidor; Martha Forero; Magnolia Vanegas; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  Protein Sci       Date:  2007-12-20       Impact factor: 6.725

Review 3.  Nanotechnology-Based Approach in Tuberculosis Treatment.

Authors:  Mohammad Nasiruddin; Md Kausar Neyaz; Shilpi Das
Journal:  Tuberc Res Treat       Date:  2017-01-22

4.  Mycobacterium tuberculosis Requires Cholesterol Oxidase to Disrupt TLR2 Signalling in Human Macrophages.

Authors:  Izabela Szulc-Kielbik; Michal Kielbik; Patrycja Przygodzka; Anna Brzostek; Jaroslaw Dziadek; Magdalena Klink
Journal:  Mediators Inflamm       Date:  2019-12-01       Impact factor: 4.711

5.  Identification of latent tuberculosis infection-related microRNAs in human U937 macrophages expressing Mycobacterium tuberculosis Hsp16.3.

Authors:  Qing-Lin Meng; Fei Liu; Xing-Yuan Yang; Xiao-Mei Liu; Xia Zhang; Chun Zhang; Zong-De Zhang
Journal:  BMC Microbiol       Date:  2014-02-12       Impact factor: 3.605

Review 6.  The Macrophage Response to Mycobacterium tuberculosis and Opportunities for Autophagy Inducing Nanomedicines for Tuberculosis Therapy.

Authors:  Retsepile E Maphasa; Mervin Meyer; Admire Dube
Journal:  Front Cell Infect Microbiol       Date:  2021-02-08       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.